CRISPR Gene-Edited Wheat Reduces Carcinogens in Toasted Bread

by Mark Thompson

For most of us, the smell of toasted bread is the quintessential start to the morning. But for decades, food scientists have been concerned with a hidden chemical byproduct of that golden-brown crust: acrylamide. Now, researchers have developed a gene-edited wheat to reduce acrylamide, potentially removing a probable carcinogen from one of the world’s most common breakfast staples without sacrificing the harvest.

The breakthrough comes from Rothamsted Research in Harpenden, Hertfordshire, where scientists utilized CRISPR genome editing to alter the DNA of wheat. By targeting the specific genes responsible for producing a particular amino acid, the team has created a crop that significantly lowers the risk of toxic compound formation during high-heat cooking, such as baking, frying, or toasting.

This development arrives at a pivotal moment for the global food system, as regulators in the United Kingdom and the European Union clash over the legality and safety of precision-bred crops. For the food industry, the stakes are not just about public health, but about meeting increasingly stringent safety benchmarks that could otherwise lead to product bans in major markets.

The Chemistry of the Crust

To understand why this gene-editing is necessary, one must glance at the molecular makeup of wheat. The plant uses an amino acid called free asparagine to store nitrogen. While harmless in its raw state, free asparagine undergoes a chemical transformation when exposed to high temperatures—a process known as the Maillard reaction, which gives bread its brown color and toasted flavor.

During this process, the amino acid converts into acrylamide. Health authorities, including the UK Food Standards Agency, classify acrylamide as a probable carcinogen. While it occurs naturally in many toasted or fried starchy foods, the goal for food scientists has long been to reduce its presence without altering the taste or texture of the food.

The Rothamsted team discovered that by using CRISPR to selectively “silence” the genes responsible for asparagine production, they could stop the toxin from forming at the source. In some tests, bread and biscuits made from this edited wheat showed acrylamide levels that fell below detectable limits, even after the bread was toasted.

Precision Editing vs. Conventional Mutation

The significance of this research lies in its precision. For years, the agricultural industry has used “conventional” breeding methods to alter crop traits. This often involves exposing seeds to chemical agents to induce random mutations, hoping for a beneficial result. However, these “shotgun” approaches often come with a hidden cost: unintended mutations that can weaken the plant.

The researchers compared their CRISPR-edited lines against wheat treated with these traditional, approved chemical mutations. The results revealed a stark contrast in efficiency and productivity.

Crispr-edited wheat lines were compared with wheat treated in the normal, approved way by having its genetic material altered to create random mutations. Photograph: John Heseltine/Alamy
Comparison of Wheat Modification Methods
Method Asparagine Reduction Impact on Crop Yield
Conventional (Chemical Mutation) ~50% ~25% Reduction (Penalty)
CRISPR (Single Gene Edit) 59% No Reduction
CRISPR (Dual Gene Edit) Up to 93% No Reduction

While the conventional method reduced asparagine by half, it caused a nearly 25% drop in yield, likely because the random mutations damaged other essential parts of the plant’s genome. The CRISPR method, by contrast, achieved up to a 93% reduction in the dual-edited line with no impact on how much wheat the farmer could harvest.

“This work demonstrates the power of Crispr technology to deliver precise, beneficial changes in crop genetics. With supportive regulatory frameworks, One can unlock significant benefits for agriculture and food systems,” said Dr. Navneet Kaur, a lead researcher from Rothamsted Research.

A Regulatory Tug-of-War

Despite the scientific success, the path from the laboratory to the toaster is complicated by geopolitics. Since Brexit, the UK has diverged from European Union rules on genetically modified organisms (GMOs). This shift has positioned the UK as a global hub for gene-editing research, culminating in the Genetic Technology (Precision Breeding) Act 2023.

A Regulatory Tug-of-War

This legislation makes it significantly easier to develop and market precision-bred crops and livestock. However, this regulatory independence is currently under pressure. The UK and EU are negotiating a new sanitary and phytosanitary (SPS) agreement. If the UK adopts “dynamic alignment” with EU food rules without a specific carve-out for precision breeding, the adoption of these safer crops could be severely slowed.

The irony is that the EU itself is tightening its grip on acrylamide. The bloc currently sets benchmark levels for the compound and intends to restrict maximum levels further this year. Because these rules apply to all products exported to the EU, UK bakers and food manufacturers may eventually find that gene-edited wheat is the only viable way to retain their products on European shelves.

What This Means for Consumers and Industry

For the average consumer, the transition to precision-bred wheat would likely be invisible. The bread would look, smell, and taste the same, but with a lower chemical risk profile. For the food industry, the benefits are more pragmatic: a way to meet evolving safety standards without incurring the massive production costs associated with crop yield loss.

Prof. Nigel Halford, who led the study at Rothamsted Research, noted that low-acrylamide wheat could enable businesses to meet safety standards without compromising product quality. He added that it offers a “meaningful opportunity to reduce the dietary exposure of consumers to acrylamide.”

Disclaimer: This article is provided for informational purposes only and does not constitute medical or nutritional advice.

The next critical checkpoint for this technology will be the outcome of the ongoing SPS negotiations between the UK and the EU, which will determine whether precision-bred wheat can move from field trials into commercial production and export. We will continue to monitor these regulatory developments as they unfold.

Do you think gene-editing is the right solution for food safety? Share your thoughts in the comments or share this story with your network.

You may also like

Leave a Comment